Bulgaria vs Solomon Islands: The number of people with susceptibility test result for rifampicin
Bulgaria
47.71
in 2021
Solomon Islands
45.52
in 2021
Bulgaria rank
115th
Solomon Islands rank
118th
The number of people with susceptibility test result for rifampicin over time
- Bulgaria
- Solomon Islands
How they compare
Bulgaria currently reports 47.71 against 45.52 in Solomon Islands, a difference of 2.19.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bulgaria ahead.
Bulgaria ranks 115th and Solomon Islands ranks 118th of 146 countries.
Across the 2 decades both report, Bulgaria averaged higher in 1 and Solomon Islands in 1.
Head to head by decade
| Decade | Bulgaria | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 80.4 | 0 | 80.4 | Bulgaria |
| 2020s | 49.92 | 55.88 | 5.96 | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bulgaria or Solomon Islands?
- Bulgaria, at 47.71 against 45.52 in Solomon Islands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bulgaria and Solomon Islands?
- 2.19, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Solomon Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Bulgaria and Solomon Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Bulgaria ranks 115th and Solomon Islands ranks 118th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.